Recruitment in pediatric clinical trials: An ethical perspective

Journal of Urology

Volumn 174, Issue 3, 2005, Pages 835-840

  Afshar, Kourosh ^a   Lodha, Abhay ^b   Costei, Adriana ^b   Vaneyke, Nancy ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Ethics; Medical; patient selection; clinical trials; pediatrics; surgical procedures; Operative

Indexed keywords

CHILD; CLINICAL TRIAL; CONFIDENTIALITY; GOVERNMENT REGULATION; HUMAN; INFORMED CONSENT; NORTH AMERICA; PATIENT SELECTION; PEDIATRIC SURGERY; PEDIATRICS; POLICY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESEARCH ETHICS; REVIEW; RISK BENEFIT ANALYSIS;

EID: 23744450416     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000169135.17634.bc     Document Type: Article

References (54)

1. Shirkey, H.: Therapeutic orphans. Pediatrics, 104: 583, 1999
2. Cote, C. J., Kauffman, R. E., Troendle, G. J. and Lambert, G. H.: Is the "therapeutic orphan" about to be adopted? Pediatrics, 98: 118, 1996
3. Lederer, S. E. and Grodin, M. A.: Historical overview: pediatric experimentation. In: Children as Research Subjects: Science, Ethics and Law. New York: Oxford University Press, pp. 3-22, 1994
4. The Nuremberg Code. Trials of War Criminals before the Nuremberg Military Tribunals. Washington, D. C.: United States Government Printing Office, 1949. Available at http:// ohsr.od.nih.gov/Nuremberg.php3. Accessed March 21, 2004
5. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. Available at http://wma.net/e/ policy/63.htm. Accessed March 21, 2004
6. U.S. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subject of Research. Washington, D. C.: Department of Health, Education and Welfare, 1978
7. The Good Clinical Practice: Consolidated Guidance. Food and Drug Administration (FDA). Available at http://www.fda.gov/ oc/gcp/regulations.html. Accessed March 21, 2004
8. Medical Research Council of Canada, Natural Sciences and Engineering Research Council of Canada and Social Sciences and Humanities Research Council of Canada: Tri-Council Policy Statement. Ottawa, Ontario Public Works and Government, 1998. Available at http://pre.ethics.gc.ca/english/policystatement/ policystatement.cfm. Accessed March 21, 2004
9. NIH Policy and Guidelines on the Inclusion of Children as Participants in Research Involving Human Subjects. March 1998. Available at http://grants.nih.gov/grants/guide/notice-files/ not98-024.html. Accessed March 21, 2004
10. Food and Drug Administration. Regulations Requiring Manufacturers Assess the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients ("The Pediatric Rule"). 21 CRF, Parts 201, 312, 314 and 601. Document No. 97N-0165. Available at www.fda.gov/cder/guidance/pedrule.pdf. Accessed March 21, 2004
11. Food and Drug Administration Modernization Act of 1997. Available at http://www.fda.gov/opacum/7modact.html. Accessed March 21, 2004
12. Best Pharmaceuticals Act for Children. January 2001. Available at http://www.fda.gov/opacom/laws/pharmkids/contents.html. Accessed March 21, 2004
13. Fried, C.: Medical Experimentation: Personal Integrity and Social Policy. Amsterdam: North-Holland Publishing, 1974
14. Levine, R. J.: Ethics and Regulations of Clinical Research, 2nd ed. Baltimore: Urban and Schwarzenberg, 1986
15. Schafer, A.: The ethics of the randomized clinical trial. N Engl J Med, 307: 719, 1982
16. Taylor, K. M., Margolese, R. G. and Soskolne, C. L.: Physician's reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. N Engl J Med, 310: 1363, 1984
17. Gifford, F.: Freedman's 'clinical equipoise' and sliding-scale all dimension-considered equipoise'. J Med Philos, 25: 399, 2000
18. Michels, K. B. and Rothman, K. J.: Update on unethical use of placebos in randomised trials. Bioethics, 17: 188, 2003
19. Freedman, B.: Equipoise and the ethics of clinical research. N Engl J Med, 317: 141, 1987
20. Freedman, B.: Equipoise and the ethics of clinical research. In: Health Care Ethics in Canada. Edited by F. Baylis. Toronto: Harcourt Brace, pp. 343-352, 1995
21. Klein, M. C., Kaczorowski, J., Robbins, J. M., Gauthier, R. J., Jorgensen, S. H. and Joshi, A. K.: Physicians' beliefs and behaviour during a randomized controlled trial of episiotomy: consequences for women in their care. CMAJ, 153: 769, 1995
22. Autret, E., Dutertre, J. P., Barbier, P., Jonville, A. P., Pierre, F. and Berger, C.: Parental opinions about biomedical research in children in Tours, France. Dev Pharmacol Ther, 20: 64, 1993
23. Meslin, E, M,: Protecting human subjects from harm through improved risk judgments. IRB, 12: 7, 1990
24. Code of Federal Regulations (CFR), Title 45, Part 46, Subpart D. Available at www.gpoaccess.gov/cfr. Accessed March 20, 2004
25. Wilson, R. and Crouch, E. A.: Risk assessment and comparisons: an introduction. Science, 236: 267, 1987
26. Wildavsky, A. and Drake, K.: Theories of risk perception: who fears what and why? Daedelus, 119: 41, 1990
27. Rowe, W. D.: An Anatomy of Risk. New York: John Wiley & Sons, 1977
28. Friedman, L. M.: Fundamentals of Clinical Trials, 3rd ed. New York, Springer-Verlag, 1998
29. Halushka vs University of Saskatchewan 52 WWR 608. Saskatchewan Court of Appeals, 1965
30. Haslam, R. H. A.: Research in children-issues of risk and harm. In: Textbook of Ethics in Paediatric Research. Edited by G. Koren. Malabar, Florida: Krieger Publishing Co., pp 25-36, 1993
31. Douglas, M. and Wildavsky, A.: Risk and Culture: An Essay on Selection of Technological and Environmental Dangers. Berkley: University of California Press, 1982
32. Slovic, P.: Perception of risk. Science, 236: 280, 1987
33. Fishhoff, B.: Treating the public with risk communication. Sci Technol Hum Values, 12: 17, 1987
34. Humber, J. M. and Almeder, R. F.: Quantitative risk assessment and the notion of acceptable risk. In: Quantitative Risk Assessment. Clifton, New Jersey: Humana Press, pp. 239-236, 1987
35. Shrader-Ferchette, K.: Values, scientific objectivity and risk analysis In: Quantitative Risk Assessment. Edited by J. M. Humber. Clifton, New Jersey: Humana Press, pp. 149-170, 1987
36. Informed consent. American Medical Association. Available at http://www.ama-assn.org/ama/pub/category. Accessed December 26, 2004
37. Hirtz, D. G. and Fitzsimmons, L. G.: Regulatory and ethical issues in the conduct of clinical research involving children. Curr Opin Pediatr, 14: 669, 2002
38. The Hospital for Sick Children: Research Ethics Board. Available at http://www.sickkids.ca/ResearchEthicsBoard. Accessed March 21, 2004
39. Nightingale, S. L.: From the Food and Drug Administration. JAMA, 274: 1578, 1995
40. van Stuijvenberg, M., Suur, M. H., de Vos, S., Tjiang, G. C., Steyerberg, E. W., Derksen-Lubsen, G. et al: Informed consent, parental awareness, and reasons for participating in a randomised controlled study. Arch Dis Child, 79: 120, 1998
41. Harth, S. C. and Thong, Y, H.; Parental perceptions and attitudes about informed consent in clinical research involving children. Soc Sci Med, 40: 1573, 1995
42. Kodish, E., Eder, M., Noll, R. B., Ruccione, K., Lange, B., Angiolillo, A. et al: Communication of randomization in childhood leukemia trials. JAMA, 291: 470, 2004
43. Snowdon, C., Garcia, J. and Elborune, D.: Making sense of randomization; responses of parents of critically ill babies to random allocation of treatment in a clinical trial. Soc Sci Med, 45: 1337, 1997
44. Zupancic, J. A., Gillie, P., Streiner, D. L., Watts, J. L. and Schmidt, B.: Determinants of parental authorization for involvement of newborn infants in clinical trials. Pediatrics, 99: E6, 1997
45. Informed consent, parental permission, and assent in pediatric practice. Committee on Bioethics. American Academy of Pediatrics. Pediatrics, 95: 314, 1995
46. Ondrusek, N., Abramovitch, R., Pencharz, P. and Koren, G.: Empirical examination of the ability of children to consent to clinical research. J Med Ethics, 24: 158, 1998
47. Certificates of Confidentiality: Background Information. Available at http://grants1.nih.gov/ grants/policy/coc/background.htm Accessed December 26, 2004
48. Santelli, J. S., Rosenfeld, W. D., DuRant, R. H., Dubler, N., Morreale, M., English, A. et al: Guidelines for adolescent health research: a position paper of the Society for Adolescent Medicine. J Adolesc Health, 17: 270, 1995
49. Levine, R. J.: Adolescents as research subjects without permission of their parents or guardians: ethical considerations. J Adolesc Health, 17: 287, 1995
50. Meaux, J. B. and Bell, P. L.: Balancing recruitment and protection: children as research subjects. Issues Compr Pediatr Nurs, 24: 241, 2001
51. Rosato, J.: The ethics of clinical trials: a child's view. J Law Med Ethics, 28: 362, 2000
52. Guidelines for ethical conduct of studies to evaluate drugs in pediatric populations. Committee on Drugs, American Academy of Pediatrics. Pediatrics, 95: 286, 1995
53. Wendler, D., Rackoff, J. E., Emanuel, E. J. and Grady, C.: The ethics of paying for children's participation in research. J Pediatr, 141: 166, 2002
54. Guidance for Institutional Review Boards and Clinical Investigators 1998 Update. Available at http://www.fda.gov/oc/ohrf irbs/toc4.htm#payment. Accessed March 20, 2004